An Overview of Generic for Emsam
(selegiline transdermal patch
) is a prescription medication that has been licensed to treat depression
. Emsam is part of a class of medicines known as monoamine oxidase inhibitors (MAOIs).
Emsam is manufactured by Bristol-Myers Squibb Company. It is currently under the protection of a patent that prevents any generic Emsam from being manufactured in the United States. Yet, if you search the Internet for "generic Emsam," you may find a number of companies selling it. The fact is that these medicines are fake, substandard, and potentially dangerous. There may be generic Emsam available from another country, but there is really no way of knowing if you are getting genuine Emsam or not. You should not buy any generic Emsam until there is an approved generic available.
When Will Generic Emsam Be Available?
The first patent for Emsam currently expires in 2018. This is the earliest possible date that a generic version of Emsam could become available. However, there are other circumstances that could come up to extend the exclusivity period of Emsam beyond 2018. These circumstances could include things such as other patents for specific Emsam uses
or lawsuits. Once Emsam goes off patent, there may be several companies that manufacture a generic Emsam drug.
Is Selegiline a Generic Emsam?
The answer is no. Selegiline
is the active ingredient in Emsam (and several other medications), but it is not a generic version of Emsam. What can be confusing is that, oftentimes, the active ingredient of a drug is referred to as its "generic name." The generic name of a medicine is different from a generic version of it. In order for there to be a generic version of a medicine, the original medicine must have gone off patent and another company (besides the original manufacturer) must have made the product.